Join
Live feed
·
PRReleasevia Quantisnow
Femasys Inc. logo
PharmaCyte  Biotech Inc. logo

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FEMY (Femasys Inc.), PMCB (PharmaCyte Biotech Inc.) and more on Quantisnow.